UNSPSC 51473703: Ritiometan

This classification denotes an anti-infective agent with the molecular formula C7H10O6S3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier J89LM8QVEE, chemically known as 2,2,2-(methylidynetris(thio))trisacetic acid but more generally known as ritiometan, which bears U.S. National Institutes of Health Compound Identifier 65787. The European Medicines Agency schedules Ritiometan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10338MIG.

UNSPSC 51473703 Ritiometan, a Commodity code, captures consumable chemical and pharmaceutical products that state and local governments procure for operational and clinical use across fire rescue, public health, and medical facilities. The recent solicitations show demand for both janitorial and operational supplies distributed through county fire departments and generic multi-source pharmaceuticals and over-the-counter products supplied through cooperative purchasing networks to state and local government facilities. Issuing bodies include county commissions, state procurement offices administering multistate cooperative purchasing alliances, and their member agencies. The procurement pattern reflects standard government supply-chain mechanics: as-needed purchasing with authorized distributor requirements, chain-of-custody tracking, product-compliance certification, and delivery scheduling to multiple operational sites.

Activity spans Florida and Minnesota with multistate reach through cooperative purchasing. Hillsborough County Board of County Commissioners posted an ITB on July 7, 2026 for janitorial and operational supplies serving 47 fire stations, with bids due July 24, 2026 and an estimated contract value of $765,679.84 for one year. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP posted January 20, 2026 with a March 26, 2026 proposal deadline for generic multi-source pharmaceuticals and OTC products to be supplied across participating state and local government facilities including Oregon; awarded vendors commence supply May 15, 2026 with contracts effective July 1, 2026. Both solicitations require vendors to demonstrate authorized distributor status, manufacturing compliance (cGMP, FDA requirements), and capability for electronic data interchange and chargeback processing through specified wholesalers.